Making it personal: the prospects for autologous pluripotent stem cell-derived therapies

An eye to the future: Researchers debate best path for stem cell–derived therapies

(2016) Shraddha Chakradhar   NATURE MEDICINE

Longitudinal Studies of a B Cell-Derived Signature of Tolerance in Renal Transplant Recipients

(2015) K. A. Newell et al.   AMERICAN JOURNAL OF TRANSPLANTATION

RIKEN suspends first clinical trial involving induced pluripotent stem cells

(2015) Ken Garber   NATURE BIOTECHNOLOGY

Cell-based therapies for Parkinson disease—past insights and future potential

(2015) Roger A. Barker et al.   Nature Reviews Neurology

Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson’s Disease

(2014) Shane Grealish et al.   Cell Stem Cell

Banking on iPSC- Is it Doable and is it Worthwhile

(2014) Susan Solomon et al.   Stem Cell Reviews and Reports

Potential and Limitation of HLA-Based Banking of Human Pluripotent Stem Cells for Cell Therapy

(2014) Casimir de Rham et al.   Journal of Immunology Research

Toward the Development of a Global Induced Pluripotent Stem Cell Library

(2013) Marc Turner et al.   Cell Stem Cell

Lack of Immune Response to Differentiated Cells Derived from Syngeneic Induced Pluripotent Stem Cells

(2013) Prajna Guha et al.   Cell Stem Cell

Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

(2013) Ryoko Araki et al.   NATURE

Long-term Clinical Outcome of Fetal Cell Transplantation for Parkinson Disease

(2013) Zinovia Kefalopoulou et al.   JAMA Neurology

Generating an iPSC Bank for HLA-Matched Tissue Transplantation Based on Known Donor and Recipient HLA Types

(2012) Craig J. Taylor et al.   Cell Stem Cell

Somatic coding mutations in human induced pluripotent stem cells

(2011) Athurva Gore et al.   NATURE

Copy number variation and selection during reprogramming to pluripotency

(2011) Samer M. Hussein et al.   NATURE

Immunogenicity of induced pluripotent stem cells

(2011) Tongbiao Zhao et al.   NATURE

Regulatory considerations for the development of autologous induced pluripotent stem cell therapies

(2010) Melissa K Carpenter et al.   Regenerative Medicine